Loratadine EP Impurity A

IMPURITIES

CAT No.# CS-CB-00047
Category Impurities
CAS 133284-74-9
Stock Status
IN-STOCK HAVE QUESTIONS ?
Molecular Weight 400.9
Molecular Formula C22H25ClN2O3
Synonyms: 11-Hydroxy Dihydro Loratadine; Loratadine USP Related Compound F; 1-Piperidinecarboxylic acid, 4-(8-chloro-6,11-dihydro-11-hydroxy-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-, ethyl ester; 4-(8-Chloro-6,11-dihydro-11-hydroxy-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylic Acid Ethyl Ester
Application Notes: 11-Hydroxy Dihydroloratadine is an impurity of Loratadine.
References: Zhong, D., et al.: Pharmazie, 49, 736 (1994), Squella, J., et al.: Talanta, 43, 2029 (1996), Ruperez, F., et al.: J. Pharm. Biomed. Anal., 29, 35 (2002),
Storage: To be stored under - 20 deg
Shipping: Free Shipping for worldwide on order above 2000 USD
Loratadine EP Impurity A Worldwide Suppliers of Loratadine EP Impurity A Impurities Clearsynth CS-CB-00047

Product rating: 9 Loratadine EP Impurity A based on 20 ratings

  1. Impurities
  2. Loratadine EP Impurity A


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Palbociclib N-Glucuronide
15. Carpropamid
16. Olmesartan N1-Trityl Impurity
17. 1-Octadecanethiol
18. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)
19. 2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene
20. α-Pinene oxide


This page contains information about Loratadine EP Impurity A Cas 133284-74-9 and its Impurities.

Loratadine EP Impurity A Loratadine EP Impurity A Worldwide Suppliers of Loratadine EP Impurity A Impurities Clearsynth 133284-74-9

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."